Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 256 AL 270

Natural Carotenoids as Neuroprotective Agents for Alzheimer's Disease: An Evidence-Based Comprehensive Review

Batool Z, Chen JH, Gao Y, Lu LW, Xu H, Liu B, Wang M, Chen F.

J Agric Food Chem. 2022 Dec 21;70(50):15631-15646. doi: 10.1021/acs.jafc.2c06206. Epub 2022 Dec 8.

Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease

Dhadda S, Kanekiyo M, Li D, Swanson CJ, Irizarry M, Berry S, Kramer LD, Berry DA.

Alzheimers Res Ther. 2022 Dec 9;14(1):182. doi: 10.1186/s13195-022-01129-x.

Synthetic, Cell-Derived, Brain-Derived, and Recombinant β-Amyloid: Modelling Alzheimer's Disease for Research and Drug Development

Varshavskaya KB, Mitkevich VA, Makarov AA, Barykin EP.

Int J Mol Sci. 2022 Nov 30;23(23):15036. doi: 10.3390/ijms232315036.

Disease-Modifying Activity of Huperzine A on Alzheimer's Disease: Evidence from Preclinical Studies on Rodent Models

Yan YP, Chen JY, Lu JH.

Int J Mol Sci. 2022 Dec 3;23(23):15238. doi: 10.3390/ijms232315238.

Safety and efficacy of plasma transfusion from exercise-trained donors in patients with early Alzheimer's disease: protocol for the ExPlas study

Tari AR, Berg HH, Videm V, Bråthen G, White LR, Røsbjørgen RN, Scheffler K, Dalen H, Holte E, Haberg AK, Selbaek G, Lydersen S, Duezel E, Bergh S, Logan-Halvorsrud KR, Sando SB, Wisløff U.

BMJ Open. 2022 Sep 6;12(9):e056964. doi: 10.1136/bmjopen-2021-056964.

A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer's and related dementias

Mafi JN, Walling AM, Villaflores C, Vangala S, Sorensen A, Cheng E, Turner A, Trutner Z, Cheng G, Arbanas JC, Waterman B, Shu S, Goldstein N, Sarkisian C.

PLoS One. 2022 Dec 20;17(12):e0277409. doi: 10.1371/journal.pone.0277409. eCollection 2022.

Astrocytic MicroRNAs and Transcription Factors in Alzheimer's Disease and Therapeutic Interventions

Nassar A, Kodi T, Satarker S, Chowdari Gurram P, Upadhya D, Sm F, Mudgal J, Nampoothiri M.

Cells. 2022 Dec 17;11(24):4111. doi: 10.3390/cells11244111.

Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer's Disease

Woodfield A, Gonzales T, Helmerhorst E, Laws S, Newsholme P, Porter T, Verdile G.

Int J Mol Sci. 2022 Dec 13;23(24):15811. doi: 10.3390/ijms232415811.

Applications of Carbon Dots for the Treatment of Alzheimer's Disease

Guo F, Li Q, Zhang X, Liu Y, Jiang J, Cheng S, Yu S, Zhang X, Liu F, Li Y, Rose G, Zhang H.

Int J Nanomedicine. 2022 Dec 23;17:6621-6638. doi: 10.2147/IJN.S388030. eCollection 2022.

Ginkgolides and bilobalide for treatment of Alzheimer's disease and COVID-19: potential mechanisms of action

Niu TT, Yuan BY, Liu GZ.

Eur Rev Med Pharmacol Sci. 2022 Dec;26(24):9502-9510. doi: 10.26355/eurrev_202212_30702.

Disease-Modifying Effects of Non-Invasive Electroceuticals on β-Amyloid Plaques and Tau Tangles for Alzheimer's Disease

Bok J, Ha J, Ahn BJ, Jang Y.

Int J Mol Sci. 2022 Dec 30;24(1):679. doi: 10.3390/ijms24010679.

Cortical hyperexcitability and plasticity in Alzheimer's disease: developments in understanding and management

van den Bos MAJ, Menon P, Vucic S.

Expert Rev Neurother. 2022 Nov-Dec;22(11-12):981-993. doi: 10.1080/14737175.2022.2170784.

A Review of the Pathogenesis and Chinese Medicine Intervention of Alzheimer's Disease

Zhao J, Yang J, Ding L, Wang F, Lin L.

J Integr Neurosci. 2022 Nov 25;22(1):2. doi: 10.31083/j.jin2201002.

Multiple approaches for the management of Alzheimer disease: Natural compounds, FDA approved drugs, and nanotechnology interventions

Leena Esam Azhar, Abdulrahman Esam Azhar, Najiah Esam Azhar.

Cell Mol Biol (Noisy-le-grand). 2022 Nov 30;68(11):8-15. doi: 10.14715/cmb/2022.68.11.2.

Objectives, Outcomes, Facilitators, and Barriers of Telemedicine Systems for Patients with Alzheimer's Disease and their Caregivers and Care Providers: A Systematic Review

Amiri P, Niazkhani Z, Pirnejad H, ShojaeiBaghini M, Bahaadinbeigy K.

Arch Iran Med. 2022 Aug 1;25(8):564-573. doi: 10.34172/aim.2022.90.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias